Pharmacovigilance in practice: erythropoiesis-stimulating agents.

about

The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC).A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors.

P2860

Q48502863-C213CCBB-02EE-4F51-B569-5B2A487042B7 Q51197806-C1F5744E-3A09-4855-8FFA-FE6FB371B797

P2860

Pharmacovigilance in practice: erythropoiesis-stimulating agents.

Item

http://www.wikidata.org/entity/Q38217083

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacovigilance in practice: erythropoiesis-stimulating agents.

@en

type

Item

label

Pharmacovigilance in practice: erythropoiesis-stimulating agents.

@en

prefLabel

Pharmacovigilance in practice: erythropoiesis-stimulating agents.

@en

P1476

Pharmacovigilance in practice: erythropoiesis-stimulating agents.

@en

P2093

David H Henry

http://www.w3.org/2001/XMLSchema#string

Eduard Gasal

http://www.w3.org/2001/XMLSchema#string

Michael Hedenus

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents

Erythropoietin or darbepoetin for patients with cancer

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

Erythropoietin for patients with malignant disease

Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia.

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes.

American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study.

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

P304

1416-1429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1002/CAM4.275

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heinz Ludwig

P577

2014-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262809514

http://www.w3.org/2001/XMLSchema#string

P698

24890561

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

4302692

http://www.w3.org/2001/XMLSchema#string

Pharmacovigilance in practice: erythropoiesis-stimulating agents.

about

P2860

P2860

Pharmacovigilance in practice: erythropoiesis-stimulating agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932